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randomized trial assessing the efficacy of
the addition of an interactive, personalized,
web-based, lifestyle intervention tool to an
existing health information web platform in
a high-risk employee population
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Omar Jamal1, Rameez Ahmad1, Muhammad A. Aziz1, Rehan Malik1, Erica S. Spatz4, Theodore Feldman1,
Jonathan Fialkow1, Emir Veledar1,8, Ricardo C. Cury5, Arthur S. Agatston1 and Khurram Nasir1,5,6,7,8*
Abstract
Background: Metabolic syndrome (MetS) and diabetes confer a high risk for developing subsequent cardiovascular
disease (CVD). Persons with MetS constitute 24–34 % of the employee population at Baptist Health South Florida
(BHSF), a self-insured healthcare organization. The Baptist Employee Healthy Heart Study (BEHHS) aims to assess the
addition of a personalized, interactive, web-based, nutrition-management and lifestyle-management program to the
existing health-expertise web platform available to BHSF employees in reducing and/or stabilizing CVD and lifestyle
risk factors and markers of subclinical CVD.
Methods/design: Subjects with MetS or Type II Diabetes will be recruited from an employee population at
BHSF and randomized to either an intervention or a control arm. The intervention arm will be given access
to a web-based personalized diet-modification and weight-modification program. The control arm will be
reminded to use the standard informational health website available and accessible to all BHSF employees.
Subjects will undergo coronary calcium testing, carotid intima-media thickness scans, peripheral arterial tonometry,
and advanced lipid panel testing at visit 1, in addition to lifestyle and medical history questionnaires. All tests will be
repeated at visits 2 and 4 with the exception of the coronary calcium test, which will only be performed at baseline
and visit 4. Visit 3 will capture vitals, anthropometrics, and responses to the questionnaires only.
(Continued on next page)
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Conclusion: Results of this study will provide information on the effectiveness of personalized, web-based,
lifestyle-management tools in reducing healthcare costs, promoting healthy choices, and reducing cardiovascular risk
in an employee population. It will also provide information about the natural history of carotid atherosclerosis and
endothelial dysfunction in asymptomatic but high-risk populations.
Trial registration: ClinicalTrials.gov registry, NCT01912209. Registered on 3 July 2013.
Keywords: Metabolic syndrome, Diabetes, Cardiovascular disease
Background
Metabolic syndrome (MetS) is the coexistence of a num-
ber of metabolic risk factors that appear to directly pro-
mote the development of atherosclerotic cardiovascular
disease (CVD) [1]. The increased risk is thought to be
greater than that conferred by any of its individual com-
ponents [2]. Persons with MetS incur higher healthcare
costs, even in the absence of CVD events or hospitaliza-
tions [3]. The elevated CVD risk and downstream costs
incurred by MetS have generated great interest in man-
agement and prevention strategies aimed at reducing the
overall CVD burden in this population.
With the incidence and prevalence of chronic diseases
such as CVD [4, 5] and diabetes [4, 6, 7] on the rise,
more organizations are implementing worksite wellness
programs. According to a Kaiser/Health Research and
Educational Trust survey [8], 92 % of employers with
200 or more employees in the United States offer well-
ness programs. The percentage of organizations offering
wellness programs in 2009 was 58 %, and the recent sur-
vey result represents a significant increase. This dramatic
increase is attributed to smaller organizations adopting
web-based health-promotion programs [8]. The Ameri-
can Heart Association recommends conducting more
workplace cardiovascular wellness research involving
high-risk populations [9]. Worksite internet-based car-
diovascular prevention and wellness programs that focus
on diet and lifestyle modification show promise as part
of a comprehensive healthcare package to be offered at
the workplace. The web-based approach provides the
promise of reach to remote workers and those with non-
conventional schedules, and can provide an affordable
platform for self-managed programs.
Enabling patients to adopt healthier lifestyles remains
a cornerstone of prevention strategies for a variety of
conditions including MetS. Lifestyle modification is a
necessary supplement to clinical therapy in order to
achieve and maintain long-term health [10, 11]. A num-
ber of methods are used to achieve lifestyle modification,
ranging from intensive supervised activities to an occa-
sional reminder by a physician [11]. Recently, web-based
tools have been increasingly employed to supplement
lifestyle interventions although their effectiveness re-
mains controversial [11, 12]. The effectiveness of online
interventions in subjects with MetS in employee popula-
tions is less well-studied [12].
Baptist Health South Florida (BHSF) is a large self-
insured organization and has a vested interest in the well-
ness of its employees. BHSF provides a number of tools to
its employees in an attempt to reduce CVD risk, including
intensive boot camps, weight loss programs [13], and a
web-based suite of tools [14–16]. All employees have access
to an online suite of wellness tools as a standard of care.
In this context, the present study aims to assess the
impact of the addition of a personalized web-based ap-
proach to the standard-of-care online tools in order to
determine the effectiveness of these tools in improving
the cardiovascular health of its employees.
Study objectives
The primary purpose of BEHHS is to assess if the
addition of a personalized, interactive, web-based, diet
and lifestyle-counselling system to an existing web-based
wellness engine will reduce/stabilize components of the
metabolic syndrome and markers of subclinical CVD in
an employee population. Primarily, this addition is hy-
pothesized to result in improvement of subclinical
markers of cardiovascular disease as a direct impact of
expected weight loss in the intervention arm versus the
control arm.
The secondary purpose of BEHHS is to determine if
the addition of a personalized web-based engine results
in a greater adoption of healthy behaviors (including
dietary habits, sleep habits, and physical activity levels)
compared to a nonpersonalized wellness engine.
Third, the study aims to assess if the addition of a per-
sonalized web-based engine to an existing platform re-
sults in stabilization of subclinical atherosclerotic disease
progression in high-risk patients.
Fourth, the study aims to document the natural history
of atherosclerotic disease (as assessed by coronary artery
calcification, carotid intima-media thickness, and periph-
eral artery tonometry) in a high-risk employee population.
Methods/design
Study design
The Baptist Employee Healthy Heart Study is a pro-
spective, randomized, nonblinded study. The study
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sample will consist of approximately 200 male and
female BHSF employees meeting the inclusion/exclusion
criteria for the study. The participants will be random-
ized into two groups: the intervention arm, Group 1, or
the control arm, Group 2 (Fig. 1).
Inclusion criteria
Study participants must be current employees of BHSF,
have access to the internet, and possess a valid email
address. In addition, participants will be required to have
a diagnosis of either Type II Diabetes or MetS. MetS is
defined as per the updated NCEP-ATP III guidelines [1].
As per guidelines, the diagnosis of MetS requires three
or more of the following: waist circumference > 40
inches in men and > 35 inches in women, fasting trigly-
ceride level ≥ 150 mg/dl or Rx, HDL-C < 40 mg/dl in
men or < 50 mg/dl in women or Rx, BP > 130/85 mmHg
or Rx, and fasting blood glucose ≥ 100 mg/dl or Rx.
Exclusion criteria
Exclusion criteria include a previous diagnosis of
CVD or history of major cardiovascular events (an-
gina, myocardial, and/or prior coronary revasculariza-
tion), known history of COPD, atrial fibrillation,
Fig. 1 Study flow chart and timeline of events
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hypotension, heart failure, valvular disease, and heart
block. BHSF employees currently participating in
other BHSF wellness programs for weight loss are
considered ineligible. Women of childbearing poten-
tial who are pregnant or seeking to become pregnant
or currently breastfeeding are excluded, as are women
with a history of bilateral mastectomy. Subjects who
are receiving active treatment for cancer or had
undergone CT scan of the chest during the year prior
to their enrollment were also excluded.
Randomization will be performed via computerized
methods, and assignment groups will be printed and
placed in sealed envelopes by nonstudy staff. On the
study visit day, the study staff will open the envelope
containing the group assignment and provide study
participants with group-specific instructions. The
study staff will undergo adequate training to prevent
selection bias.
Description of the intervention program
Subjects randomized to the intervention program will
be given an access key to a personalized web-based
program. The program includes personalized diet and
weight guidance, meal planners, shopping list gener-
ator, recipe finder, weight tracker, exercise tracker,
dining out, and fast food guides. Participants are able
to track their diet with a food journal each day, and
enter their weight change over time. The intervention
program provides personalized nutrition counseling
and weight-loss advice from a registered dietician.
The participants receive phone and e-mail access to a
dietician. In addition, the interactive web-portal pro-
vides weight loss guidance in response to the partici-
pant use of the online weight tracker. Participants
receive tips and suggestions on how to make changes
in their diet and lifestyle each time they log in to the
website. Community support is also available to the
participants through an online forum comprising
other participants of the program. The use of the
above-mentioned tools is optional for participants in
the intervention program.
Description of the standard of care online wellness
program
Control group subjects will continue to receive ac-
cess to a web-based infomational health program
available to all Baptist Health employees. Partici-
piants will be shown how to access the website and,
if needed, will be given information on how to reset
their passwords. The program provides educational
material regarding healthy diet and physical activity.
It also provides health trackers and goal setting for
certain health targets.
Data collection and storage
All anthropometric, clinical examination, and survey
data will be collected on standardized case report
forms, which are then transferred to an electronic
database. The data will be assessed for consistency
prior to upload, and a number of quality control and
validation checks will be performed within the soft-
ware to ensure accuracy of the data. EndoPAT data
will be obtained via machine-generated excel sheets,
which will then be uploaded into the electronic data-
base. An individual coronary artery calcium (CAC)
score will be obtained in the form of a radiologist re-
port, which is then entered into the electronic data
capture system. Blood testing results will be trans-
ferred electronically from the Quest Diagnostics-
Nichols Institute to the study center periodically.
Fitbit data (physical activity tracker data) will be col-
lected periodically from the Fitbit online portal with
the consent of study participants.
Recruitment
The primary recruitment strategy will consist of sending
a series of monthly emails to all BHSF employees
informing them of the study. Study information will be
placed on the BHSF intranet website, and study flyers
and posters will be placed throughout the various BHSF
entities. We will also reach potential participants by pla-
cing study information in the weekly BHSF employee
newsletters. Potential participants will be screened via
telephone or email by the study staff using a standard-
ized questionnaire to assess them for study eligibility.
Inclusion and exclusion criteria will be assessed based
on self-report.
The secondary recruitment strategy will consist of
informational tables set up by study staff throughout
various BHSF entities, at which, study staff will
provide study information to potential participants
through presentations. Additionally, staff will provide
blood pressure, lipid, and finger-stick glucose screen-
ing for potential study participants who are unsure of
their lab values.
Consent and enrollment
Participants meeting study eligibility criteria will be
scheduled for an appointment at the study center. Par-
ticipants are required to fast for 9–12 hours prior to
study procedures. A copy of the consent form will be
provided to potential participants prior to the visit.
Upon arrival in the clinic, each participant will be asked
to review and sign the informed consent.
Study procedures
The following study procedures are conducted at
baseline, month 4, and month 12, with the exception
Post et al. Trials  (2016) 17:308 Page 4 of 9
of the coronary artery calcium scoring, which will be
repeated only at month 12. The month 8 study visit
will capture vitals, anthropometrics, and questionnaire
responses only. Table 1 provides a detailed breakdown
of procedures that will be conducted at each study
visit.
1. Ensuring study eligibility
At the beginning of the first visit, the study
coordinator reviews the participant’s medical
history with the participant to ensure study
eligibility. After confirming eligibility,
participants are then required to review and
sign an informed consent form.
2. Measurement of vital signs
Seated blood pressure: Following 5 minutes
of rest in the sitting position, blood pressure
is determined in the right arm following the
American Heart Association guidelines [17].
Body weight, heart rate, and blood pressure
are obtained prior to venipuncture.
Heart rate: Following 5 minutes of rest in the
sitting position, the heart rate is assessed by
palpation for 30 seconds and recorded as beats
per minutes after multiplying by 2.
3. Urine pregnancy test (if applicable)
A urine pregnancy test is performed on all
female participants of childbearing age to
exclude pregnancy. Women who have a
positive pregnancy test will be excluded.
4. Anthropometry
a. Body weight: Subjects are weighed, without their
shoes, on a calibrated scale after heavy objects
(such as keys and coins) have been removed from
their pockets. The results are recorded to the
nearest 0.2 pounds.
b. Height: Height is measured by standing next to a
standardized scale after removing footwear.
c. Abdominal circumference: The subject’s abdomen
is cleared of all clothing and accessories.
The feet are positioned shoulder width apart
and arms crossed over the chest in a relaxed
manner. Using the NIH protocol, the waist
circumference measurement is taken at the
top of the iliac crest using an anthropometric
tape. Ensuring that the measuring tape is
positioned in a horizontal plane around
the abdomen, tension is applied to the tape
to ensure a snug fit without causing skin
indentation. At the end of a normal
expiration, the measurement is taken to the
nearest 0.5 cm.
d. Hip measurement: Hip circumference is
measured at the level of the greatest girth,
which is usually at the level of the trochanters.
Measurements are made to the nearest 0.5 cm.
e. Body fat percentage: The bioelectrical impedance
method is utilized, with a handheld device being
used to calculate body fat percentage (Omron
HBF-306C) [18].
Table 1 Baptist Employee Healthy Heart Study (BEHHS) procedures
Visit 1 (Enrollment) Visit 2 (4 Months) Visit 3 (8 Months) Visit 4 (12 Months)
Consent X
Vitals X X X X
Family history/medical history X
Urine pregnancy test (if applicable) X X
Anthropometry (weight, height, waist and hip circumference,
body fat %)
X X X X
Venipuncture X X X
Standard and advanced lipid testing (TC, LDL, HDL, triglycerides,
lipoprotein(a), apolipoprotein B, LDL and HDL subclasses)
EndoPAT X X X
Carotid ultrasound (cIMT) X X X
Demographic questionnaire X
Healthy Days and Sleep Questionnaire X X X X
Healthy Behaviors Questionnaire X X X X
Smoking and Alcohol Use Questionnaire X X X X
Medication Use Questionnaire X X X X
Exercise and Physical Activity Questionnaire X X X X
CT appointment referral (if applicable) X X
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5. Venipuncture
Approximately 30 ml of venous blood will be drawn,
labeled, processed, and shipped to Quest Diagnostics
for advanced cardiovascular testing, which includes
fasting plasma glucose, standard lipid panel
testing, and advanced markers. Advanced markers
include ApoB, Lp(a), homocysteine, Lp-Pla2,
hsCRP, fibrinogen, insulin, NT–proBNP, vitamin
D, Omega 3 and 6, and others. A genetic panel
that includes KIF6, CYP2C19, ApoE, LPA-Aspirin,
LPA-Intron 25, 4q25-AF, and 9p21-MI risk
genotypes will also be performed (see Table 2).
6. Carotid intima-media thickness (cIMT) scanning
The study will employ a Panasonic CardioHealth
Station automated carotid ultrasound screening
device [19] for fully automated cIMT measurements
using a single transducer angle. The mean cIMT
measurement is defined as the mean of 24
spatial measurements performed over a 1-cm
region in the far wall of the common carotid
artery. In addition, atherosclerotic plaque is
defined as any obvious focal luminal
encroachment > 1.00 mm.
7. Endothelial function testing
The reactive hyperemia index (RHI) to assess
endothelial function and augmentation index (AI)
to assess arterial stiffness are measured using the
Itamar EndoPAT 2000 system [20]. The test
procedure involves a baseline reading with the
EndoPAT probes on the index finger for 5 minutes.
A blood pressure cuff is then applied to the
nondominant arm for the next 5 minutes to
occlude blood supply, and a reading is taken during
this time. After 5 minutes of occlusion of the
nondominant arm, the pressure is released.
Blood flow to the arm resumes, which causes
blood vessels to dilate, at which time the EndoPAT
machine calculates stiffness in the arterial walls.
The vessel wall reactivity is a comparison of the
pre-occlusion and postocclusion blood flow and
is reported as the reactive hyperemia index.
8. Questionnaires
Participants are asked to complete a series of
questionnaires at each study visit (Table 3).
The domains assessed will included demographics,
past medical history, family history, socioeconomic
status, dietary habits, physical activity, current
medications (including dose and frequency), and
self-perception of health.
9. Coronary artery calcium score (CAC)
Subjects over the age of 35 undergo CAC
scanning. Coronary arteries are scanned by
noncontrast multiple detector computed
tomography (MDCT) (acquisition time:
100 msec, 3-mm slice thickness) during
end-diastole. Coronary calcium is classified
with a CT threshold of 130 Hounsfield units
(HU) involving three contiguous voxels for
identification of a calcific lesion, resulting in
a minimum lesion area of 1.02 mm. The average
radiation dose is 0.5–1 mSv. The scanning
procedures and protocols used in this study are
Table 2 Baptist Employee Healthy Heart Study (BEHHS) genetic
testing
Genotype Clinical utility
KIF6 Provides genetic information about a person’s
increased risk for heart disease and reduction of
heart disease events with atorvastatin or
pravastatin therapy
CYP2C19 Provides genetic information about a person’s
metabolism of certain drugs such as clopidogrel
ApoE Provides genetic information about a person’s
increased risk for heart disease and response to
different amounts of dietary fat
LPA-Aspirin Provides genetic information about a person’s
increased risk for heart disease and reduction
of heart disease events with aspirin therapy
4q25-AF Provides genetic information about a person’s
increased risk for atrial fibrillation and risk for
stroke caused by atrial fibrillation
LPA-Intron 25 Provides genetic information about a person’s
increased risk for heart disease
9p21-MI Provides genetic information about a person’s
increased risk for a myocardial infarction at an
early age, abdominal aortic aneurysm, and
coronary heart disease
Table 3 Major data points in Baptist Employee Healthy Heart
Study (BEHHS) surveys
Survey title Main data elements
Demographic Age, ethnicity, family income, education,
family size
Healthy Days and Sleep Physical and mental health status during
the past month. Sleep duration and quality.
Diet Fruit and vegetable consumption,
“unhealthy” food consumption (fast food
and red meat etc), Mediterranean diet
assessment
Smoking and Alcohol Use Frequency and type of alcohol
consumption, smoking history including
number of years and quantity smoked
Exercise and Physical
Activity
Duration in minutes per week of vigorous
and moderate physical activity during work,
travel, recreational time. Sedentary time/day
Medical History History of stroke, TIA, hypercholesterolemia,
hypertension, asthma, sleep apnea, others
Family History Age of diagnosis of diabetes, stroke,
myocardial infarction, COPD, PCI/CABG
Medication History Current medications, dose, frequency and
route of administration
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the same as those used in previous studies and
follow current Baptist Health South Florida
radiology protocols. If a CAC score ≥ 400 is found,
the patient and the patient’s primary
care physician will be notified of the CT scan
results immediately.
10.Fitbit—physical activity tracker
All participants are provided with a Fitbit pedometer
on their second study visit. An online account will
be created for them, and login information will be
provided to participants to enable them to track
their physical activity. Physical activity data is
retrieved periodically from the online portal and
stored electronically.
Statistical analysis
Sample size calculations
Our hypothesis is that the addition of a personalized,
interactive, web-based diet and lifestyle counselling sys-
tem to an existing, web-based, wellness engine will re-
duce/stabilize components of the MetS, so differences in
values of components of the MetS and markers of sub-
clinical CVD (CVD is not apparent at baseline), will be
observed on follow-up visits at 4, 8, and 12 months.
A two-by-two repeated measures design consists of
two groups of subjects, each measured at two time
points. In this case, the primary goal of the study is to
compare the change of weight across time in group 1 to
the change across time in group 2. Sample sizes of 85 in
group 1 and 85 in group 2 achieve 80 % power to detect
a difference in mean weight changes of 5.8 lbs. with a
standard deviation of 10.0 lbs. at the first time point, a
standard deviation of 10.0 lbs. at the second time point,
and a correlation between measurement pairs of 0.100.
The significance level (alpha) is 0.05 using a two-sided,
two-sample t-test.
Group sample sizes of 85 and 85 achieve 80 % power
to detect a difference in BMI of 1.019 kg/m2, 1.359 kg/
m2, or 1.699 kg/m2 in a design with four repeated mea-
surements and having a compound symmetry covariance
structure when the standard deviation is 3, 4, or 5, the
correlation between observations on the same subject is
0.500, and the alpha level is 0.050.
Primary analysis
The primary endpoint is BMI reduction and the im-
provement/stabilization of measures of subclinical CVD.
Additionally, we will examine changes in anthropometric
indices (waist circumference, waist to hip ratio, and per-
centage of body fat), metabolic parameters, conven-
tional/advanced lipid testing, inflammatory marker
panel, systolic and diastolic blood pressure, dietary and
physical activity scores, coronary artery calcification,
carotid intima-media thickness, and endothelial
function. The primary null hypothesis is that no differ-
ence exists between the treatment groups in the out-
comes measured.
Analysis will be conducted using the intention-to-treat
principle; that is, all subjects who were randomized will
be included in the data analysis regardless of completion
of the study status. Continuous variables (e.g., age and
biochemical variables) will be assessed for normality by
examining graphically and by statistical methods.
Categorical variables will be described using frequency
distributions, whereas continuous variables will be
described using means and standard deviations for nor-
mally distributed variables, and median (interquartile
range) for non-normally distributed variables. Differ-
ences relating to study-arm assignment in these variables
between groups will be evaluated using chi-square tests
for categorical variables and independent t-tests for con-
tinuous variables.
MDCT data analysis
The lesion score will be calculated with the area density
method, by multiplying the lesion area by a density fac-
tor derived from the maximal Hounsfield unit within the
area as described by Agatston and Janowitz [21]. The
density factor will be assigned in the following manner:
1 for lesions whose maximal density was 130–199 HU, 2
for lesions 200–299 HU, 3 for lesions 300–399 HU, and
4 for lesions ≥ 400 HU. A total CAC score will be deter-
mined by summing the individual lesion scores from
each of four anatomic sites (left main, left anterior
descending, circumflex, and right coronary arteries).
Quality control and assurance
All data are subjected to periodic quality control checks by
the database administrator and study coordinators. Add-
itionally, all study data is subject to a periodic audit by the
Institutional Review Board at Baptist Health South Florida.
Cohort surveillance and follow-up
Contact information is obtained for each study partici-
pant at baseline, and study coordinators contact all study
participants to schedule follow-up visits. At each follow-
up visit, standardized questionnaires are used to capture
pertinent health and lifestyle information.
Notification of incidental study findings
At each visit, participants will be asked if they or their
primary care physicians would like to receive test results.
Copies of all study test results (including in-clinic mea-
surements) will be mailed to participants in both arms
of the study and their primary care physicians after every
study visit. Any incidental findings or conditions that
merit urgent medical evaluation (e.g., CAC ≥ 400), will
be reported to participants and their physicians via
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telephone and/or email as soon as they are identified.
Additionally, all participants will be able to contact
the principal investigator in order to discuss their test
results at any time.
Discussion
The BEHHS is the first randomized trial at BHSF to as-
sess the effectiveness of a personalized, interactive web-
based nutrition and lifestyle management program in a
high-risk employee population. We hope this will result
in the development of a “turn-key” program that could
be utilized by employee health groups to improve meta-
bolic health and reduce subclinical cardiovascular dis-
ease burden via large-scale, low-cost interventions.
The Baptist Employee Healthy Heart Study (BEHHS)
will also allow us to determine potential risk factors in-
volved in the development of subclinical cardiovascular
disease in an asymptomatic employee population and,
therefore, aid in devising strategies to prevent CVD. The
use of internet-based employee wellness programs can
present an opportunity to minimize absenteeism and
presenteeism and decrease healthcare costs. Baicker et
al. indicated that employee wellness programs offer an
average of 3.27 USD reductions in medical costs for
every dollar spent [22].
The BEHHS study will also permit the determination
of interactions between risk factors and the noninvasive
assessment of subclinical cardiovascular disease and pro-
gression over time to symptomatic disease. It may also
give more insight into the pathophysiology of athero-
sclerosis and provide a more personalized approach to
the prevention of atherosclerotic disease. The current
models of CVD risk prediction provides limited oppor-
tunities to assess the impact of risk-factor modification
and lifestyle changes. BEHHS aims to expand the use of
CAC and cIMT and their correlation with genetic sus-
ceptibility of an individual to atherosclerotic disease, and
development of new risk prediction models that would
help identify individuals predicted to have a high lifetime
risk but are designated as low risk using current models.
The use of advanced noninvasive imaging techniques
(CAC and cIMT) in harmony with genetic and advanced
lipoprotein testing provides a unique cluster of data to
determine prevalence and progression of atherosclerosis
and enabling quantification of anatomical and biological
characteristics of subclinical atherosclerosis in a high
risk population.
Limitations
A major limitation of the study is the lack of blinding of
study subjects, which is not possible due to the obvious
nature of the intervention. This study has a small sample
size, which may prove underpowered to achieve second-
ary objectives.
Conclusion
In conclusion, the Baptist Employee Healthy Heart
Study has been designed to investigate subclinical ath-
erosclerosis using advanced noninvasive cardiovascular
imaging in an asymptomatic high-risk population and
personalized internet-based interventions to improve
cardiovascular disease prevention in the early stages
of atherosclerosis.
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